Clinical Evidence

At Artivion, we partner with cardiovascular surgeons to develop cutting-edge technologies to treat patients with aortic diseases. We are committed to collecting and sharing clinical data related to our aortic-centered technologies to further the science of aortic disease treatment.

Check out some of our most recent clinical data releases.

PERSEVERE US IDE
Interim Results

Presented 60th Annual Meeting of The Society of Thoracic Surgeons, January 2024.

On-X® Aortic Heart Valve Post Approval Study Results

Presented 104th Annual Meeting of The American Association for Thoracic Surgery, April 2024.

Mid-term Survival, Clinical and Hemodynamic Outcomes of a New Generation Mechanical Mitral Valve Prosthesis

Presented 60th Annual Meeting of The Society of Thoracic Surgeons, January 2024.

The First Interim Results of the European Multicenter NEOS Study

Presented at the European Association for Cardio-Thoracic Surgery Annual Meeting, October 2023.

Caution: AMDS is an investigational device limited by federal (or United States) law to investigational use only within the United States. E-vita Open Neo is not commercially approved in the Untied States. All products and indications are not available/approved in all markets. Refer to the Instructions for Use for indications, contraindications, precautions, and potential adverse events. All trademarks are owned by Artivion, Inc. or its subsidiaries. ©2024 Artivion, Inc. All rights reserved.